BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
- Product NDC
- 51407-200
- 11-digit product format
- 514070200
- Labeler code
- 51407
- Product ID
- 51407-200_a2dfbeda-9b7b-064f-e053-2995a90a9250
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- butalbital, acetaminophen and caffeine
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Golden State Medical Supply
- Application
- ANDA207118
- Marketing category
- ANDA
- Marketing start
- 2016-10-28
- Marketing end
- 0000-00-00
- Substance
- ACETAMINOPHEN; CAFFEINE; BUTALBITAL
- Active strength
- 300 mg/1; mg/1; mg/1
- Pharmacologic classes
- Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE],Barbiturates [CS],Barbiturate [EPC]
- DEA schedule
- CIII
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51407-200-01 | 51407020001 | 100 CAPSULE in 1 BOTTLE (51407-200-01) | 100 capsule | 2019-02-11 | 0000-00-00 | No | No | Current |